The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

 

This Article
-Abstract
-Full Text

Supplementary Material

Supplements to: Steigbigel RT et al. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection. N Engl J Med 2008;359:339-54.

These appendixes have been provided by the authors to give readers additional information about their work.

Download IconDownload PDF File of Supplementary Appendix 1: Members of the BENCHMRK (Blocking Integrase in Treatment Experienced Patients with a Novel Compound against HIV, Merck) Study Teams.

Download IconDownload PDF File of Supplementary Appendix 2: Supplementary Tables and Figures.


 

This Article
-Abstract
-Full Text

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.